Clinical Trial

Ultrasound Guided Erectror Spinae Block Versus Intracavitary During Medical Thoracoscopy

Study acronym: ESPB
Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated May 12, 2026 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary aim: is to compare the effect of US guided ESP block at two levels versus intracavitary blockade in medical thoracoscopy on total peri-procedural (intraoperative and post-operative 12 hours) nalbuphine consumption (mg) during medical thoracoscopy. Secondary aims: Time to first rescue analgesia, postoperative VAS, haemodynamics, recovery time (Aldert \> 9), and adverse events
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-30.
Trial Details
NCT Number NCT07572019
Lead Sponsor Kafrelsheikh University
Conditions PLEURA DISEASE
Enrollment 100 participants
Start Date 2026-05-15
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-12